RNA Outsourcing Resources
-
Analytical Method Release And Stability Platform For RNA Drug Substance
3/14/2025
We offer comprehensive analytical support across the R&D space, including method development, validation, process characterization, in-process testing, process validation, and GMP release testing.
-
Consolidating The Supply Chain For mRNA
2/12/2024
Learn about the first end-to-end cGMP facility that was developed for mRNA manufacturing to address the shortage of CDMOs and the inadequate and inefficient supply chain options for sourcing GMP mRNA.
-
mRNA: How To Build A Custom Program Using CDMO Services
1/4/2023
Development of RNA-based therapies sits at the cutting edge of vaccine and oncology innovation, in addition to holding promise in dozens of other therapeutic areas.
-
Strategies For A More Secure Outsourcing Bottom Line
7/9/2024
A panel of experts from across the pharmaceutical/biopharmaceutical industry recently shared their experiences in mitigating financial risk before partnering with a contract research organization (CRO).
-
PCR In Clinical Development
4/23/2026
Strengthen your clinical development strategy by leveraging the right PCR approach and robust assay validation to deliver accurate, reliable results with confidence.
-
Pioneering The Future Of Pharmaceutical Supply Chains
Drive the efficiency and resiliency of supply chains by integrating automation, AI, and effective communication, ensuring the successful distribution of lifesaving medicinal products.
-
Pharmaceutical Supply Chain Management Best Practices
9/13/2024
Explore strategies for effective supply chain management and overcoming modern supply chain challenges in the pharmaceutical industry.
-
Why Bioanalysis Needs To Break Free From Manual Bottlenecks
9/2/2025
Bioanalysis remains one of the most persistent bottlenecks in drug development, with CROs displaying inefficiencies that are no longer operational nuisances but strategic liabilities.
-
Exploring The Spatial Distribution Of mRNA-Lipid Nanoparticles Using MALDI MSI
4/23/2025
Learn how leveraging high-resolution MALDI-MSI can advance the development of lipid nanoparticle-based therapies, uncovering spatial biodistribution, pharmacokinetics, and organ-specific variability.
-
5 Outdated Practices Holding Back Modern Bioanalysis
10/20/2025
Bioanalysis must replace outdated paper, manual processes, and disjointed systems with integrated, automated platforms for continuous validation, efficiency, compliance, and to support complex modern therapies.